• Publications
  • Access to mental healthcare: how should pharm...
Publication - published on 10 Oct 2016

Access to mental healthcare: how should pharma companies channel their efforts?

Suvi Karuranga, Researcher, and Jayasree K. Iyer, Executive Director, share their thoughts and findings on access to mental healthcare with the aim of starting a conversation about how manufacturers’ efforts can be channeled in the best directions, and to identify where more can be done.

The authors describe the challenges, the medicines and the ways that the pharmaceutical industry is currently engaged with issues surrounding mental health, in the hopes that a clear direction on what actions are needed can be discussed.

The article was published in the Huffington Post


Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.